Works by Aarnio, Richard

Results: 11

SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study.
Published in:
Diabetes Care, 2024, v. 47, n. 9, p. 1630, doi. 10.2337/dc24-0470
By:
- Latva-Rasku, Aino;
- Rebelos, Eleni;
- Tuisku, Jouni;
- Aarnio, Richard;
- Bhowmik, Achol;
- Keskinen, Helmi;
- Laurila, Sanna;
- Lahesmaa-Hatting, Minna;
- Pekkarinen, Laura;
- Isackson, Henrik;
- Kirjavainen, Anna K.;
- Koffert, Jukka;
- Heurling, Kerstin;
- Nummenmaa, Lauri;
- Ferrannini, Ele;
- Oldgren, Jonas;
- Oscarsson, Jan;
- Nuutila, Pirjo
Publication type:
Article
[11C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 2, p. 266, doi. 10.1007/s00259-022-05969-5
By:
- Sun, Lihua;
- Aarnio, Richard;
- Herre, Erika Atencio;
- Kärnä, Salli;
- Palani, Senthil;
- Virtanen, Helena;
- Liljenbäck, Heidi;
- Virta, Jenni;
- Honkaniemi, Aake;
- Oikonen, Vesa;
- Han, Chunlei;
- Laurila, Sanna;
- Bucci, Marco;
- Helin, Semi;
- Yatkin, Emrah;
- Nummenmaa, Lauri;
- Nuutila, Pirjo;
- Tang, Jing;
- Roivainen, Anne
Publication type:
Article
Lower abdominal adipose tissue cannabinoid type 1 receptor availability in young men with overweight.
Published in:
Obesity (19307381), 2023, v. 31, n. 7, p. 1844, doi. 10.1002/oby.23770
By:
- Pekkarinen, Laura;
- Kantonen, Tatu;
- Oikonen, Vesa;
- Haaparanta‐Solin, Merja;
- Aarnio, Richard;
- Dickens, Alex M.;
- von Eyken, Annie;
- Latva‐Rasku, Aino;
- Dadson, Prince;
- Kirjavainen, Anna K.;
- Rajander, Johan;
- Kalliokoski, Kari;
- Rönnemaa, Tapani;
- Nummenmaa, Lauri;
- Nuutila, Pirjo
Publication type:
Article
ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease – Study Protocol and Baseline Characteristics.
Published in:
Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.826423
By:
- Snellman, Anniina;
- Ekblad, Laura L.;
- Koivumäki, Mikko;
- Lindgrén, Noora;
- Tuisku, Jouni;
- Perälä, Merja;
- Kallio, Lila;
- Lehtonen, Riina;
- Saunavaara, Virva;
- Saunavaara, Jani;
- Oikonen, Vesa;
- Aarnio, Richard;
- Löyttyniemi, Eliisa;
- Parkkola, Riitta;
- Karrasch, Mira;
- Zetterberg, Henrik;
- Blennow, Kaj;
- Rinne, Juha O.
Publication type:
Article
Quantification of the purinergic P2X7 receptor with [ 11 C]SMW139 improves through correction for brain-penetrating radiometabolites.
Published in:
Journal of Cerebral Blood Flow & Metabolism, 2023, v. 43, n. 2, p. 258, doi. 10.1177/0271678X221126830
By:
- Brumberg, Joachim;
- Aarnio, Richard;
- Forsberg, Anton;
- Marjamäki, Päivi;
- Kerstens, Vera;
- Moein, Mohammad M;
- Nag, Sangram;
- Wahlroos, Saara;
- Kassiou, Michael;
- Windhorst, Albert D;
- Halldin, Christer;
- Haaparanta-Solin, Merja;
- Fazio, Patrik;
- Oikonen, Vesa;
- Rinne, Juha O;
- Varrone, Andrea
Publication type:
Article
SV2A PET shows hippocampal synaptic loss in cognitively unimpaired APOE ε4/ε4 homozygotes.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 12, p. 8802, doi. 10.1002/alz.14327
By:
- Snellman, Anniina;
- Tuisku, Jouni;
- Koivumäki, Mikko;
- Wahlroos, Saara;
- Aarnio, Richard;
- Rajander, Johan;
- Karrasch, Mira;
- Ekblad, Laura L.;
- Rinne, Juha O.
Publication type:
Article
P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study.
Published in:
EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01186-3
By:
- Lehto, Jussi;
- Aarnio, Richard;
- Tuisku, Jouni;
- Sucksdorff, Marcus;
- Koivumäki, Esa Mikko;
- Nylund, Marjo;
- Helin, Semi;
- Rajander, Johan;
- Danon, Jonathan;
- Gilchrist, Jayson;
- Kassiou, Michael;
- Oikonen, Vesa;
- Airas, Laura
Publication type:
Article
New improved radiometabolite analysis method for [18F]FTHA from human plasma: a test-retest study with postprandial and fasting state.
Published in:
EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01114-5
By:
- Aarnio, Richard;
- Kirjavainen, Anna;
- Rajander, Johan;
- Forsback, Sarita;
- Kalliokoski, Kari;
- Nuutila, Pirjo;
- Milicevic, Zvonko;
- Coskun, Tamer;
- Haupt, Axel;
- Laitinen, Iina;
- Haaparanta-Solin, Merja
Publication type:
Article
Correction: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA.
Published in:
2024
By:
- Alzghool, Obada M.;
- Aarnio, Richard;
- Helin, Jatta S.;
- Wahlroos, Saara;
- Keller, Thomas;
- Matilainen, Markus;
- Solis, Junel;
- Danon, Jonathan J.;
- Kassiou, Michael;
- Snellman, Anniina;
- Solin, Olof;
- Rinne, Juha O.;
- Haaparanta‑Solin, Merja
Publication type:
Correction Notice
Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA.
Published in:
EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01085-7
By:
- Alzghool, Obada M.;
- Aarnio, Richard;
- Helin, Jatta S.;
- Wahlroos, Saara;
- Keller, Thomas;
- Matilainen, Markus;
- Solis, Junel;
- Danon, Jonathan J.;
- Kassiou, Michael;
- Snellman, Anniina;
- Solin, Olof;
- Rinne, Juha O.;
- Haaparanta-Solin, Merja
Publication type:
Article
Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA.
Published in:
EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01103-8
By:
- Alzghool, Obada M.;
- Aarnio, Richard;
- Helin, Jatta S.;
- Wahlroos, Saara;
- Keller, Thomas;
- Matilainen, Markus;
- Solis, Junel;
- Danon, Jonathan J.;
- Kassiou, Michael;
- Snellman, Anniina;
- Solin, Olof;
- Rinne, Juha O.;
- Haaparanta-Solin, Merja
Publication type:
Article

Works by Aarnio, Richard

SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study.

[<sup>11</sup>C]carfentanil PET imaging for studying the peripheral opioid system in vivo: effect of photoperiod on mu-opioid receptor availability in brown adipose tissue.

Lower abdominal adipose tissue cannabinoid type 1 receptor availability in young men with overweight.

ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease – Study Protocol and Baseline Characteristics.

Quantification of the purinergic P2X<sub>7</sub> receptor with [ 11 C]SMW139 improves through correction for brain-penetrating radiometabolites.

SV2A PET shows hippocampal synaptic loss in cognitively unimpaired APOE ε4/ε4 homozygotes.

P2X <sub>7</sub>-receptor binding in new-onset and secondary progressive MS – a [<sup>11</sup>C]SMW139 PET study.

New improved radiometabolite analysis method for [<sup>18</sup>F]FTHA from human plasma: a test-retest study with postprandial and fasting state.

Correction: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [<sup>11</sup>C]SMW139 and [<sup>18</sup>F]F-DPA.

Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [<sup>11</sup>C]SMW139 and [<sup>18</sup>F]F-DPA.

Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [<sup>11</sup>C]SMW139 and [<sup>18</sup>F]F-DPA.